Skip to content

Assisted Fluid Management in Patients Undergoing Major Abdominal and Orthopedic Surgery

Manual Versus Assisted Fluid Management in Patients Undergoing Major Abdominal and Orthopedic Surgery: A Randomized Controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03779373
Acronym
AFM
Enrollment
0
Registered
2018-12-19
Start date
2019-04-01
Completion date
2020-07-30
Last updated
2019-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Goal Directed Fluid Therapy

Brief summary

This study will compare a group of patients managed with a manual GDFT protocol (using the EV1000 monitoring device; Edwards Lifesciences, Irvine, USA) to a group of patients managed using a decision support system for GDFT guidance (implemented on the same EV1000 monitoring) in patients undergoing major abdominal and orthopedic surgery.

Detailed description

Many trials have indicated that goal-directed fluid therapy (GDFT) strategies may benefit high-risk surgical patients but these strategies are infrequently implemented. It has also been shown that without any goal or protocol for fluid resuscitation, large inter- and intra-provider variability exist and have been correlated with marked variations in patient outcomes. Even under ideal study conditions, strict adherence to GDFT protocols is hampered by the workload and concentration required for consistent implementation.Haemodynamic monitors and protocols alone do not enable optimal fluid titration to be provided consistently to all patients - there must also be appropriate and timely interpretation and intervention. To address this problem of consistency and protocol adherence, a clinical decision support system, Assisted Fluid Management (AFM), has been designed to help ease some of the workload associated with GDFT protocol implementation. The AFM system (released on the European market in March 2017) may help increase GDFT protocol adherence while leaving direction and guidance in the hands of the care providers. This system can suggest fluid bolus administration, analyse the effects of the bolus, and continually re-assess the patient for further fluid requirements. A recent published study demonstrated that the implementation of the AFM for GDFT guidance resulted in a significantly longer period during surgery with a SVV \<13% with a reduced total amount of fluid administered without any difference in postoperative complications. Therefore the goal of this randomized controlled trial is to compare a manual GDFT approach ( standard of care actually in the department) versus an Assisted fluid management approach (using the AFM mode) on the incidence of minor postoperative complications.

Interventions

OTHERUse of a decision support system on the EV1000 monitor (AFM mode)

The way to administer fluid is based on the same monitoring device but will differ by the way fluid is given ( following a manual GDFT protocol versus following recommendation from an active clinical deicsion support system for fluid administration called AFM (assisted fluid management)

Sponsors

APHP
CollaboratorOTHER
Erasme University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Prospective randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* All adult patients in the operating room scheduled for a major abdominal & orthopedic surgery requiring a cardiac output monitoring (EV1000). * Written informed consent received before surgery.

Exclusion criteria

* Minor Patients. * No french speaking. * Atrial fibrillation or severe arythmia.

Design outcomes

Primary

MeasureTime frameDescription
composite criteria of minor postoperative complications30 days postsurgeryThis composite score includes 8 items : 1. postoperative nausea and vomiting 2. delirium and confusion 3. Infection of surgical site 4. urinary infection 5. acute kidney injury (KDIGO I & II classiciation) 6. paralytic ileus 7. other infection (skin, catheter, unknown etc) 8. Readmission to the hospital within 30 days postoperative

Secondary

MeasureTime frameDescription
Percentage of Time spent during the procedure with a Cardiac index >2.5l/min/m2Postoperative day 1Percentage of Time spent during the procedure with a Cardiac index \>2.5l/min/m2
composite criteria of major postoperative complications30 days postsurgeryThis composite score includes 14 items : 1. stoma dehiscence 2. Peritonitis 3. Sepsis 4. wound dehiscence 5. bleeding requiring a redo surgery 6. pulmonary embolism 7. pulmonary edema 8. Pneumonia 9. acute coronary syndrome 10. atrial fibrillation 11. stroke 12. Dialysis 13. non scheduled redo surgery 14. 30days mortality (all causes)
cardiac index over the procedurePostoperative day 1average cardiac index over the surgery
stroke volume over the procedurePostoperative day 1average stroke volume over the procedure
Percentage of Time spent during the procedure with a stroke volume variation < 13%Postoperative day 1Percentage of Time spent during the procedure with a stroke volume variation \< 13%
Total Fluid received during the procedurePostoperative day 1amount of fluid received during surgery
Net fluid balancePostoperative day 1Net fluid balance at the end of the ICU stay
Postoperative acute care unit or intensive care unit length of stay30 days postsurgeryPostoperative acute care unit or intensive care unit length of stay
Hospital length of stay30 days postsurgeryhospital length of stay
stroke volume variation over the procedurePostoperative day 1average stroke volume variation over the procedure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026